Table of Content




1. Executive Summary


2. Global Pediatric Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Pediatric Vaccine Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Pediatric Vaccine Market by Vaccine Type
3.3.1: Monovalent
3.3.2: Multivalent

3.4: Global Pediatric Vaccine Market by Technology
3.4.1: Live Attenuated
3.4.2: Inactivated
3.4.3: Subunit
3.4.4: Toxoid
3.4.5: Conjugate
3.4.6: Others

3.5: Global Pediatric Vaccine Market by Application
3.5.1: Infectious Disease
3.5.2: Cancer
3.5.3: Allergy
3.5.4: Pneumococcal Disease
3.5.5: Influenza
3.5.6: Measles, Mumps, and Rubella (MMR)?
3.5.7: Others




4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Pediatric Vaccine Market by Region
4.2: North American Pediatric Vaccine Market
4.2.1: North American Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
4.2.2: North American Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR)?, and Others

4.3: European Pediatric Vaccine Market

4.3.1: European Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
4.3.2: European Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR)?, and Others

4.4: APAC Pediatric Vaccine Market

4.4.1: APAC Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
4.4.2: APAC Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR)?, and Others

4.5: ROW Pediatric Vaccine Market

4.5.1: ROW Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
4.5.2: ROW Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR)?, and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Pediatric Vaccine Market by Vaccine Type
6.1.2: Growth Opportunities for the Global Pediatric Vaccine Market by Technology
6.1.3: Growth Opportunities for the Global Pediatric Vaccine Market by Application

6.1.4: Growth Opportunities for the Global Pediatric Vaccine Market by Region

6.2: Emerging Trends in the Global Pediatric Vaccine Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Pediatric Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pediatric Vaccine Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: GlaxoSmithKline
7.2: Merck & Co
7.3: Sanofi
7.4: Pfizer
7.5: Johnson & Johnson
7.6: Bharat Biotech International
7.7: Serum Institute of India